p53 and tumor suppression.
Van Dyke
Terry
T
Department of Genetics and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA.
D000818:Animals; D017209:Apoptosis / Q000528:radiation effects; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism; D004249:DNA Damage / Q000502:physiology*; D016158:Genes, p53 / Q000502:physiology*; D008223:Lymphoma / Q000209:etiology; D051379:Mice; D008822:Mice, Transgenic; D009369:Neoplasms / Q000235:genetics*; D013953:Thymus Neoplasms / Q000209:etiology; D025803:Tumor Suppressor Protein p14ARF / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D014916:Whole-Body Irradiation
C417743:Cdkn2a protein, mouse; D019941:Cyclin-Dependent Kinase Inhibitor p16; D025803:Tumor Suppressor Protein p14ARF; D016159:Tumor Suppressor Protein p53